Filter
1218
Filtered Results: 1218
Text search:
pharmaceutical
performance
Featured
Recommendations
108
New Publications
381
Language
Document type
No document type
717
Studies & Reports
187
Guidelines
161
Strategic & Response Plan
59
Manuals
56
Training Material
17
Fact sheets
10
Situation Updates
8
Resource Platforms
3
Countries / Regions
Ethiopia
59
India
55
Kenya
51
Global
40
Uganda
35
Nigeria
31
South Africa
31
Liberia
29
Sierra Leone
26
Rwanda
23
Ghana
22
Tanzania
22
Zambia
22
Western and Central Europe
21
Nepal
19
Namibia
19
Malawi
18
Bangladesh
17
Africa
16
Ukraine
13
Philippines
12
Cambodia
12
Zimbabwe
11
Eastern Europe
11
Indonesia
11
Lesotho
10
Syria
10
Latin America and the Carribbean
10
Congo, Democratic Republic of
9
West and Central Africa
9
Myanmar / Burma
9
Botswana
8
South–East Asia Region
7
Cameroon
6
Senegal
6
East and Southern Africa
6
Eswatini/ Swaziland
6
Benin
5
Thailand
4
Guinea
4
Asia
4
Albania
3
Burkina Faso
3
Germany
3
Middle East and North Africa
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Brazil
3
South Sudan
3
China
2
Jordan
2
Jamaica
2
Lebanon
2
Egypt
2
Iraq
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Chile
1
Iran
1
Fiji
1
Laos
1
Kyrgyzstan
1
Niger
1
Afghanistan
1
Peru
1
Bulgaria
1
Mozambique
1
Haiti
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Japan
1
United Kingdom
1
Southern Africa
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Sudan
1
Mali
1
Chad
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
572
Clinical Guidelines
71
Public Health
69
Key Resources
47
Pharmacy & Technologies
27
Women & Child Health
25
Capacity Building
11
Toolboxes
Pharmacy
98
COVID-19
77
AMR
77
TB
73
Mental Health
57
HIV
48
Rapid Response
34
Planetary Health
29
NCDs
26
Caregiver
25
NTDs
24
Conflict
21
Global Health Education
21
Health Financing Toolbox
20
Refugee
8
Ebola
8
Polio
8
Specific Hazards
7
Disability
5
Natural Hazards
4
Cholera
2
Health Financing
2
Social Ethics
1
Zika
1
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
An Advocate’s Guide: Strategic Indicators for Universal Access to Sexual and Reproductive Health and Rights
recommended
This guide was prepared to enable advocates to use data
when advocating for universal access to SRHR at the national,
regional and global levels. It is a direct outcome of the Strategic
SRHR Indicators workshop held in Kuala Lumpur, Malaysia on
21-22 August for the project “Strengthening the N...
From 2000 to 2010, Rwanda implemented comprehensive health sector reforms to strengthen the public health system, with the aim of reducing maternal and newborn deaths in line with Millennium Development Goal 5, among many other improvements in national health. Based on a systematic review of the lit...
Measuring progress towards universal health coverage.
This sixth edition of Health at a Glance Asia/Pacific presents a set of key indicators of health status, the determinants of health, health care resources and utilisation, health care expenditure and financing and quality of care across 27 Asia-...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
These guidelines were written for anyone trying to meet and solve the challenges of operating a warehouse today. They are an important reference tool for managers and staff, whether they are constructing a new warehouse, implementing a new warehouse system, or redesigning their current system.
G...
G...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Guidelines for the production of extemporaenous formulations and hospital based sterile preparations
In order to streamline and effectively control compounding of medicinal products in hospitals and pharmacies, these Guidelines for Production of Extemporaneous and Hospital Based Sterile Preparations has been crafted. The purpose of these guidelines therefore is to assist pharmacists in ...
Second Edition
AIDS Medicines and diagnostics services
July 2015
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...
Curriculum reform efforts to enhance training on rational medicine use (RMU) and AMR should pay particular attention to ensuring that the right topics are integrated and the right teaching-learning methodologies are adopted.
J Nepal Health Res Counc 2013 May;11(24):198-204
